{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:22:41Z","timestamp":1787671361605,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:p>Orthobiologic agents, including platelet-rich plasma, connective tissue progenitor cells derived from bone marrow, adipose, and other tissues, and purified cytokines and small peptides, have tremendous potential to target deficiencies in soft-tissue healing. The principal limitation currently is the variability in the composition and biologic activity of orthobiologic formulations, making it difficult to choose the optimal treatment for a specific tissue or pathology. Current data suggest that orthobiologics are \u201csymptom-modifying,\u201d but there is little evidence that they can lead to true tissue regeneration (\u201cstructure-modifying\u201d). A critically important need at this time is to identify sentinel markers of potency and biologic activity for different orthobiologic formulations so that we can match the treatment to the desired biologic effect for a specific tissue or pathology. Improved understanding of the underlying cellular and molecular mechanisms of tissue degeneration and repair will allow a precision medicine approach where we can choose the optimal orthobiologic treatment of specific orthopaedic problems. It is important for the clinician to be aware of the evolving regulatory status of orthobiologic treatments. Emerging therapies such as the use of exosomes and gene therapy approaches hold great promise as improved methods to both treat symptoms and affect tissue regeneration.<\/jats:p>","DOI":"10.5435\/jaaos-d-22-00808","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:34:55Z","timestamp":1683048895000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["Orthobiologics: Current Status in 2023 and Future Outlook"],"prefix":"10.5435","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-9880","authenticated-orcid":false,"given":"Scott A.","family":"Rodeo","sequence":"first","affiliation":[{"name":"From the Sports Medicine Institute, Hospital for Special Surgery, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1038\/s41598-021-90174-x","article-title":"In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis","volume":"11","author":"Zahir","year":"2021","journal-title":"Sci Rep"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00063030-200721050-00004","article-title":"Autologous conditioned serum in the treatment of orthopedic diseases: The orthokine therapy","volume":"21","author":"Wehling","year":"2007","journal-title":"BioDrugs"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00590-020-02623-4","article-title":"Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials","volume":"30","author":"Hohmann","year":"2020","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0363546516643716","article-title":"The effectiveness of platelet-rich plasma in the treatment of tendinopathy: A meta-analysis of randomized controlled clinical trials","volume":"45","author":"Fitzpatrick","year":"2017","journal-title":"Am J Sports Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0363546520909397","article-title":"Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Belk","year":"2021","journal-title":"Am J Sports Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"e0156137","DOI":"10.1371\/journal.pone.0156137","article-title":"Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee","volume":"11","author":"Mariani","year":"2016","journal-title":"PLoS One"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1038\/s41598-021-83025-2","article-title":"Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy","volume":"11","author":"Bansal","year":"2021","journal-title":"Sci Rep"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1177\/0363546521998725","article-title":"Effect of autologous expanded bone marrow mesenchymal stem cells or leukocyte-poor platelet-rich plasma in chronic patellar tendinopathy (with gap >3 mm): Preliminary outcomes after 6 months of a double-blind, randomized, prospective study","volume":"49","author":"Rodas","year":"2021","journal-title":"Am J Sports Med"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.arthro.2021.05.023","article-title":"Platelet-rich plasma has better results for retear rate, pain, and outcome than platelet-rich fibrin after rotator cuff repair: A systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Li","year":"2022","journal-title":"Arthroscopy"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9315815","article-title":"A prospective, randomized, double-blind, parallel-group, placebo-controlled study evaluating meniscal healing, clinical outcomes, and safety in patients undergoing meniscal repair of unstable, complete vertical meniscal tears (bucket handle) augmented with platelet-rich plasma","volume":"2018","author":"Kaminski","year":"2018","journal-title":"Biomed Res Int"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"2325967120964534","DOI":"10.1177\/2325967120964534","article-title":"Platelet-rich plasma augmentation for isolated arthroscopic meniscal repairs leads to significantly lower failure rates: A systematic review of comparative studies","volume":"8","author":"Sochacki","year":"2020","journal-title":"Orthop J Sports Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s10195-022-00630-1","article-title":"Platelet-rich plasma (PRP) augmentation does not result in more favourable outcomes in arthroscopic meniscal repair: A meta-analysis","volume":"23","author":"Migliorini","year":"2022","journal-title":"J Orthop Traumatol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.arthro.2019.11.004","article-title":"Anterior cruciate ligament reconstruction with platelet-rich plasma: A systematic review of randomized control trials","volume":"36","author":"Davey","year":"2020","journal-title":"Arthroscopy"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The international society for cellular therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00003086-200202000-00008","article-title":"Connective tissue progenitors: Practical concepts for clinical applications","volume":"395","author":"Muschler","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: Time to change the name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00264-014-2391-1","article-title":"Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: A case-controlled study","volume":"38","author":"Hernigou","year":"2014","journal-title":"Int Orthop"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/0963689719863793","article-title":"Additional use of synovial mesenchymal stem cell transplantation following surgical repair of a complex degenerative tear of the medial meniscus of the knee: A case report","volume":"28","author":"Sekiya","year":"2019","journal-title":"Cel Transpl"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial","volume":"99","author":"Vega","year":"2015","journal-title":"Transplantation"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.arthro.2019.07.024","article-title":"Comparison of preparation techniques for isolating subacromial bursa-derived cells as a potential augment for rotator cuff repair","volume":"36","author":"Morikawa","year":"2020","journal-title":"Arthroscopy"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.jse.2022.05.009","article-title":"Subacromial bursa increases the failure force in a mouse model of supraspinatus detachment and repair","volume":"31","author":"Lebaschi","year":"2022","journal-title":"J Shoulder Elbow Surg"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0363546519829034","article-title":"Are amniotic fluid products stem cell therapies? A study of amniotic fluid preparations for mesenchymal stem cells with bone marrow comparison","volume":"47","author":"Panero","year":"2019","journal-title":"Am J Sports Med"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0363546520908847","article-title":"Adipose stem cell-derived exosomes decrease fatty infiltration and enhance rotator cuff healing in a rabbit model of chronic tears","volume":"48","author":"Wang","year":"2020","journal-title":"Am J Sports Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/d41586-022-01518-0","article-title":"Gene therapy's comeback: How scientists are trying to make it safer","volume":"606","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1177\/0363546516638342","article-title":"Local administration of simvastatin stimulates healing of an avascular meniscus in a rabbit model of a meniscal defect","volume":"44","author":"Zhang","year":"2016","journal-title":"Am J Sports Med"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"27149","DOI":"10.1038\/srep27149","article-title":"IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy","volume":"6","author":"Millar","year":"2016","journal-title":"Sci Rep"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0363546508315470","article-title":"Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle","volume":"36","author":"Bedair","year":"2008","journal-title":"Am J Sports Med"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"6673525","DOI":"10.1155\/2021\/6673525","article-title":"Metformin and fibrosis: A review of existing evidence and mechanisms","volume":"2021","author":"Wu","year":"2021","journal-title":"J Diabetes Res"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.arthro.2018.11.038","article-title":"Effect of recombinant human parathyroid hormone on rotator cuff healing after arthroscopic repair","volume":"35","author":"Oh","year":"2019","journal-title":"Arthroscopy"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1177\/0363546520926471","article-title":"Zoledronic acid substantially improves bone microarchitecture and biomechanical properties after rotator cuff repair in a rodent chronic defect model","volume":"48","author":"Schanda","year":"2020","journal-title":"Am J Sports Med"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jcyt.2022.02.009","article-title":"Standardization of cellular therapy terminology, coding and labeling: A review","volume":"24","author":"Ashford","year":"2022","journal-title":"Cytotherapy"},{"key":"R37-20250503","article-title":"Trends in utilization, demographics and costs of platelet-rich plasma injections: A ten-year nationwide investigation","author":"Magruder","year":"2023","journal-title":"Phys Sportsmed"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/15563316221105880","article-title":"Variability in patient-incurred costs and protocols of regenerative medicine procedures for musculoskeletal conditions in the United States","volume":"19","author":"Charnoff","year":"2022","journal-title":"HSS J"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.arthro.2020.02.004","article-title":"What is the appropriate price for platelet-rich plasma injections for knee osteoarthritis? A cost-effectiveness analysis based on evidence from level I randomized controlled trials","volume":"36","author":"Bendich","year":"2020","journal-title":"Arthroscopy"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2106\/JBJS.19.01446","article-title":"The cost-effectiveness of platelet-rich plasma injections for knee osteoarthritis: A Markov decision analysis","volume":"102","author":"Rajan","year":"2020","journal-title":"J Bone Joint Surg Am"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-22-00808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:42:17Z","timestamp":1787668937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-22-00808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-22-00808","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"2022-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}